Country Trust Bank’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.1K | Sell |
339
-3
| -0.9% | -$450 | ﹤0.01% | 200 |
|
|
2026
Q1 | $52.2K | Hold |
342
| – | – | ﹤0.01% | 185 |
|
|
2025
Q4 | $47.2K | Hold |
342
| – | – | ﹤0.01% | 199 |
|
|
2025
Q3 | $43.9K | Buy |
342
+110
| +47% | +$13.4K | ﹤0.01% | 212 |
|
|
2025
Q2 | $28.1K | Buy |
232
+38
| +20% | +$4.28K | ﹤0.01% | 233 |
|
|
2025
Q1 | $21.6K | Hold |
194
| – | – | ﹤0.01% | 210 |
|
|
2024
Q4 | $18.9K | Hold |
194
| – | – | ﹤0.01% | 227 |
|
|
2024
Q3 | $22.3K | Hold |
194
| – | – | ﹤0.01% | 214 |
|
|
2024
Q2 | $20.7K | Hold |
194
| – | – | ﹤0.01% | 210 |
|
|
2024
Q1 | $18.8K | Sell |
194
-79
| -29% | -$8.1K | ﹤0.01% | 205 |
|
|
2023
Q4 | $27.6K | Buy |
273
+79
| +41% | +$7.63K | ﹤0.01% | 194 |
|
|
2023
Q3 | $19.8K | Hold |
194
| – | – | ﹤0.01% | 213 |
|
|
2023
Q2 | $19.6K | Hold |
194
| – | – | ﹤0.01% | 213 |
|
|
2023
Q1 | $17.8K | Hold |
194
| – | – | ﹤0.01% | 211 |
|
|
2022
Q4 | $17.6K | Sell |
194
-290
| -60% | -$24.4K | ﹤0.01% | 230 |
|
|
2022
Q3 | $37K | Hold |
484
| – | – | ﹤0.01% | 201 |
|
|
2022
Q2 | $41K | Hold |
484
| – | – | ﹤0.01% | 200 |
|
|
2022
Q1 | $42K | Sell |
484
-23
| -5% | -$1.99K | ﹤0.01% | 219 |
|
|
2021
Q4 | $44K | Buy |
507
+313
| +161% | +$26K | ﹤0.01% | 226 |
|
|
2021
Q3 | $16K | Hold |
194
| – | – | ﹤0.01% | 297 |
|
|
2021
Q2 | $18K | Hold |
194
| – | – | ﹤0.01% | 266 |
|
|
2021
Q1 | $17K | Sell |
194
-35
| -15% | -$3.14K | ﹤0.01% | 260 |
|
|
2020
Q4 | $22K | Buy |
229
+35
| +18% | +$3.06K | ﹤0.01% | 230 |
|
|
2020
Q3 | $17K | Hold |
194
| – | – | ﹤0.01% | 226 |
|
|
2020
Q2 | $17K | Sell |
194
-41
| -17% | -$3.54K | ﹤0.01% | 203 |
|
|
2020
Q1 | $19K | Sell |
235
-325,776
| -100% | -$29.1M | ﹤0.01% | 191 |
|
|
2019
Q4 | $30.9M | Sell |
326,011
-8,138
| -2% | -$730K | 1.22% | 32 |
|
|
2019
Q3 | $29M | Sell |
334,149
-25,672
| -7% | -$2.31M | 1.26% | 28 |
|
|
2019
Q2 | $32.9M | Sell |
359,821
-41,675
| -10% | -$3.53M | 1.43% | 23 |
|
|
2019
Q1 | $34.6M | Sell |
401,496
-52,354
| -12% | -$4.2M | 1.54% | 19 |
|
|
2018
Q4 | $34.9M | Sell |
453,850
-816
| -0.2% | -$63.5K | 1.74% | 13 |
|
|
2018
Q3 | $35.1M | Sell |
454,666
-70,254
| -13% | -$5.19M | 1.62% | 17 |
|
|
2018
Q2 | $35.5M | Buy |
524,920
+100,628
| +24% | +$6.94M | 1.53% | 23 |
|
|
2018
Q1 | $30.7M | Sell |
424,292
-60,270
| -12% | -$4.59M | 1.46% | 24 |
|
|
2017
Q4 | $36.5M | Sell |
484,562
-9,757
| -2% | -$736K | 1.57% | 23 |
|
|
2017
Q3 | $38M | Buy |
494,319
+2,093
| +0.4% | +$158K | 1.72% | 19 |
|
|
2017
Q2 | $36.8M | Buy |
492,226
+22,846
| +5% | +$1.62M | 1.76% | 18 |
|
|
2017
Q1 | $31.2M | Buy |
469,380
+6,519
| +1% | +$434K | 1.56% | 21 |
|
|
2016
Q4 | $30.2M | Sell |
462,861
-5,224
| -1% | -$339K | 1.53% | 21 |
|
|
2016
Q3 | $33.1M | Sell |
468,085
-824
| -0.2% | -$60K | 1.71% | 18 |
|
|
2016
Q2 | $34.7M | Buy |
468,909
+566
| +0.1% | +$39.1K | 1.86% | 11 |
|
|
2016
Q1 | $30.4M | Sell |
468,343
-5,406
| -1% | -$368K | 1.63% | 24 |
|
|
2015
Q4 | $36.5M | Sell |
473,749
-46,050
| -9% | -$3.66M | 2% | 7 |
|
|
2015
Q3 | $42.8M | Sell |
519,799
-33,052
| -6% | -$2.94M | 2.35% | 3 |
|
|
2015
Q2 | $48.7M | Buy |
552,851
+653
| +0.1% | +$59.9K | 2.45% | 2 |
|
|
2015
Q1 | $48.8M | Sell |
552,198
-396
| -0.1% | -$35.1K | 2.45% | 2 |
|
|
2014
Q4 | $45.9M | Buy |
552,594
+871
| +0.2% | +$72.2K | 2.3% | 3 |
|
|
2014
Q3 | $46.5M | Sell |
551,723
-294
| -0.1% | -$23.8K | 2.39% | 5 |
|
|
2014
Q2 | $44.8M | Buy |
+552,017
| New | +$43.4M | 2.25% | 6 |
|
Other funds holding NVS
Country Trust Bank's NVS Position: Q2 2026 in Review
Country Trust Bank reduced its Novartis (NVS) stake by 0.88% in Q2 2026, selling an estimated $450 and leaving 339 shares worth $53.1K. The position accounts for ﹤0.01% of the portfolio, ranked #200.
Country Trust Bank first reported a position in NVS in Q2 2014 and has held it in 49 quarters since. The position peaked at $48.8M in Q1 2015. 1,269 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Country Trust Bank held 339 shares of Novartis worth $53.1K as of Q2 2026.
- Country Trust Bank sold 3 Novartis shares in Q2 2026, an estimated $450.
- Novartis made up ﹤0.01% of Country Trust Bank's portfolio in Q2 2026, its #200 holding.
- Country Trust Bank first reported a position in Novartis in Q2 2014 and has held it in 49 quarters since.
- Country Trust Bank's Novartis position peaked at $48.8M in Q1 2015.
- 1,269 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Country Trust Bank's 13F filing for Q2 2026, filed 15 Jul 2026.